Current location - Plastic Surgery and Aesthetics Network - Plastic surgery and medical aesthetics - Medical beauty has formed a clear and complete industrial chain. What will be the future trend of the industry?
Medical beauty has formed a clear and complete industrial chain. What will be the future trend of the industry?
The market scale of light medical beauty occupies half of the country, and the proportion of users exceeds 83%.

Compared with the way of medical beauty that requires surgery, non-surgical Light medical cosmetology is safer and more flexible, and the recovery period is shorter, which has become the choice of more and more beauty lovers. According to the data of New Oxygen's White Paper on Medical Beauty Industry (20021), the market size of Light medical cosmetology was 49.2% in the medical beauty projects in 20021year, which was not far from the surgical projects.

In terms of the proportion of user types, the number of light medical beauty users increased from 72.6% in 20 19 to 83. 1% in 20021year, becoming the mainstream among medical beauty users.

Botulinum toxin injection and hyaluronic acid account for most of the market share of injection medical beauty projects.

Injection medical beauty project is one of the main projects of light medical beauty. Judging from the consumption structure of 202 1, botulinum toxin for injection and hyaluronic acid account for most of the market share of medical beauty projects for injection, and the consumption of botulinum toxin accounts for more than 52%, which is an absolute mainstream medical beauty project.

In 2020, Aimeike ranked first in China medical beauty hyaluronic acid market.

In the market ranking of medical beauty hyaluronic acid terminal products in China in 2020, beauty lovers accounted for more than 12%, ranking first, followed by Huaxi Bio and Haohai Bio, accounting for 7.5% and 2.5% respectively.

Botulinum toxin foreign products still account for the majority.

At present, China botulinum toxin products outside China still occupy the mainstream, accounting for about 60%. The main products are Botox and Jishi. China products account for about 40% of the market, and the main products include Hengli.

To sum up, light medical beauty occupies half of the China market, and the user scale is increasing year by year. Hyaluronic acid and botulinum toxin account for the vast majority of injection items. In the hyaluronic acid market, companies such as Aimeike and Huaxi Bio are temporarily ahead. In the botulinum toxin market, foreign products occupy more shares.

—— The above data refer to the Analysis Report on Market Demand Forecast and Investment Strategic Planning of China Medical and Beauty Industry by Forward-looking Industry Research Institute.